Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021
January 05, 2021 07:55 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.
January 04, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
Arch Therapeutics, Inc. to Present at the Virtual Investor KOL Roundtable
October 22, 2020 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics to Present at The LD 500 Virtual Conference on Tuesday, September 1 at 1 PM ET
August 26, 2020 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
SANUWAVE Continues to Increase Clinical Symposia Presence With SAWC Fall 2019
October 16, 2019 09:00 ET
|
SANUWAVE Health, Inc.
Symposia and Posters Presenting Compelling Clinical Evidence in Treating Diabetic Foot Ulcers With dermaPACE®System SUWANEE, GA, Oct. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE...
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference
September 03, 2019 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
April 24, 2019 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of products for dermal science and biosurgical applications, today...
SANUWAVE Health, Inc. Announces a New Shock This Blog Regarding an Interview With Michael Stolarski, the Owner, President, and CEO of Premier Shockwave, Inc. and Premier Shockwave Wound Care, Inc.
December 27, 2018 08:00 ET
|
SANUWAVE Health, Inc.
SUWANEE, GA, Dec. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of...
SANUWAVE Announces Exhibition at Fall SAWC 2018 Including a Poster and Three Presentations - Visit us at Booth #441
October 17, 2018 08:00 ET
|
SANUWAVE Health, Inc.
SUWANEE, GA , Oct. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit at SAWC (Symposium on Advanced Wound...
SANUWAVE Announces Selection to Exhibit in the New Product Showcase at SAWC in Charlotte, April 25-29, 2018
April 11, 2018 09:07 ET
|
SANUWAVE Health, Inc.
SUWANEE, GA, April 11, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company’s flagship wound care device, the dermaPACE® System, has been selected to...